← Insider buys

SIBN

SI-BONE, Inc. · Healthcare

Insiders sold $9.4M of SI-BONE, Inc. in the last 12 months and bought none

$0Bought, 12 mo
$9.4MSold, 12 mo
$962.7MMarket cap

SIBN over the last year

No insider buys filed in this year

SIBN after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Every filing

229 insider filings since 2018, newest first

SIBNSell

Laura Francis · Chief Executive Officer

$762K−9.1%Oct 14
SIBNSell

Michael A. Pisetsky · SVP, Ops & Adm/Chief Legal Ofr

$57K−1.1%Oct 6
SIBNSell

Anshul Maheshwari · Chief Op & Financial Officer

$94K−2.3%Oct 6
SIBNSell

Jeffrey W Dunn · Director

$369K−55.5%Oct 5
SIBNSell

Jeffrey W Dunn · Director

$378K−55.5%Sep 3
SIBNSell

Laura Francis · Chief Executive Officer

$523K−8.2%Aug 26
SIBNSell

Laura Francis · Chief Executive Officer

$1.1M−15.0%Aug 21
SIBNSell

Anshul Maheshwari · Chief Op & Financial Officer

$337K−6.7%Aug 21
SIBNSell

Laura Francis · Chief Executive Officer

$279K−2.9%Aug 18
SIBNSell

Michael A. Pisetsky · SVP, Ops & Adm/Chief Legal Ofr

$69K−1.3%Aug 18
SIBNSell

Anshul Maheshwari · Chief Financial Officer

$87K−1.8%Aug 18
SIBNSell

Jeffrey W Dunn · Director

$369K−55.5%Aug 5
SIBNSell

Michael A. Pisetsky · SVP, Ops & Adm/Chief Legal Ofr

$52K−1.1%Jul 6
SIBNSell

Anshul Maheshwari · Chief Financial Officer

$56K−1.3%Jul 6
SIBNSell

Jeffrey W Dunn · Director

$55K−18.2%Jun 8
SIBNSell

Timothy E Davis Jr · Director

$104K−10.0%Jun 1
SIBNSell

Laura Francis · Chief Executive Officer

$220K−2.9%May 20
SIBNSell

Michael A. Pisetsky · SVP, Ops & Adm/Chief Legal Ofr

$55K−1.3%May 20
SIBNSell

Anshul Maheshwari · Chief Financial Officer

$69K−1.8%May 20
SIBNSell

Anshul Maheshwari · CFO

$43K−1.0%Apr 3
SIBNSell

Michael A. Pisetsky · SVP, Ops, Adm, Chief Legal Ofr

$40K−1.0%Apr 3
SIBNSell

Mika Nishimura · Director

$57K−11.0%Mar 13
SIBNSell

Michael A. Pisetsky · SVP, Ops, Adm, Chief Legal Ofr

$319K−7.0%Feb 18
SIBNSell

Anshul Maheshwari · CFO

$331K−7.0%Feb 18
SIBNSell

Anthony J Recupero · Insider

$324K−8.0%Feb 18
SIBNSell

Laura Francis · CEO

$1.4M−9.0%Feb 18
SIBNSell

Jeffrey W Dunn · Director

$426K−18.0%Jan 12
SIBNSell

Michael A. Pisetsky · SVP, Ops, Adm, Chief Legal Ofr

$68K−1.0%Jan 6
SIBNSell

Anshul Maheshwari · CFO

$103K−3.0%Jan 6
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$72K−1.0%Jan 6
SIBNSell

Michael A. Pisetsky · SVP, Ops, Adm, Chief Legal Ofr

$395K−8.0%Dec 19
SIBNSell

Anshul Maheshwari · CFO

$374K−9.0%Dec 19
SIBNSell

Jeffrey W Dunn · Director

$387K−14.0%Dec 11
SIBNSell

Anshul Maheshwari · CFO

$26K−1.0%Nov 25
SIBNSell

Anshul Maheshwari · CFO

$31K−1.0%Nov 20
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$75K−3.0%Nov 20
SIBNSell

Laura Francis · CEO

$126K−2.0%Nov 20
SIBNSell

Anshul Maheshwari · CFO

$45K−2.0%Oct 4
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$57K−2.0%Oct 4
SIBNSell

Anshul Maheshwari · CFO

$34K−1.0%Aug 20
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$84K−2.0%Aug 20
SIBNSell

Laura Francis · CEO

$138K−1.0%Aug 20
SIBNSell

Anshul Maheshwari · CFO

$43K−2.0%Jul 5
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$55K−2.0%Jul 5
SIBNSell

Anshul Maheshwari · CFO

$37K−1.0%May 17
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$90K−2.0%May 17
SIBNSell

Anshul Maheshwari · CFO

$37K−1.0%Apr 4
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$66K−2.0%Apr 4
SIBNSell

Anthony J Recupero · Pres, Commercial Ops

$56K−1.0%Mar 14
SIBNSell

Mika Nishimura · Director

$41K−11.0%Mar 14
About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.